NVAX logo

Novavax (NVAX) Total Expenses

Annual Total Expenses

$1.12 B
-$1.12 B-49.95%

December 31, 2023

Summary

Performance

1-Year Change

-49.95%

3-Year Change

+155.72%

5-Year Change

+439.32%

15-Year Change

+453.46%

NVAX Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

86.94%
NVAX annual total expenses is higher than 86.94% of companies in Healthcare sector

High & Low

All-time High

$2.24 B
NVAX annual total expenses is currently -49.95% below its historical high of $2.24 billion

3-Year Low

$1.12 B
NVAX annual total expenses is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
NVAX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
NVAX next annual earnings announcement is scheduled for Feb 28, 2025

OtherNVAXexpensesmetrics:

Annual Interest Expense

$14.42 M
NVAX annual interest expense is $14.42 million

Annual Income Tax

$2.03 M
NVAX annual income tax is $2.03 million

Annual Operating Expenses

$779.13 M
NVAX annual total operating expenses is $779.13 million

Annual Cost Of Goods Sold

$343.77 M
NVAX annual cost of goods sold is $343.77 million

Quarterly Total Expenses

$218.53 M
-$35.96 M-14.13%

September 30, 2024

Summary

Performance

3-Month Change

-14.13%

1-Year Change

+47.96%

3-Year Change

+121.94%

5-Year Change

+731.73%

NVAX Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.05%
NVAX quarterly total expenses is higher than 84.05% of companies in Healthcare sector

High & Low

All-time High

$755.49 M
NVAX quarterly total expenses is currently -71.07% below its historical high of $755.49 million

3-Year Low

$98.46 M
NVAX quarterly total expenses is currently +121.94% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NVAX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
NVAX next earnings announcement is scheduled for Feb 28, 2025

OtherNVAXexpensesmetrics:

Quarterly Interest Expense

$4.24 M
NVAX quarterly interest expense is $4.24 million

Quarterly Income Tax

-$1.03 M
NVAX quarterly income tax is -$1.03 million

Quarterly Operating Expenses

$157.91 M
NVAX quarterly total operating expenses is $157.91 million

Quarterly Cost Of Goods Sold

$60.62 M
NVAX quarterly cost of goods sold is $60.62 million

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

Annual Total Expenses

$1.12 B
NVAX annual total expenses is $1.12 billion

Annual Cost Of Goods Sold

$343.77 M
NVAX annual cost of goods sold is $343.77 million

Annual Operating Expenses

$779.13 M
NVAX annual total operating expenses is $779.13 million

NVAX Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-50.0%+48.0%
3 y3 years+155.7%+121.9%
5 y5 years+439.3%+731.7%

NVAX Total Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-50.0%at low-71.1%+121.9%
5 y5-year-50.0%+657.4%-71.1%+2249.3%
alltimeall time-50.0%>+9999.0%-71.1%+2023.0%

Novavax Total Expenses History

DateAnnualQuarterly
Sep 2024
-
$218.53 M(-14.1%)
Jun 2024
-
$254.49 M(+6.6%)
Mar 2024
-
$238.69 M(-45.4%)
Dec 2023
$1.12 B(-50.0%)
$436.97 M(+195.9%)
Sep 2023
-
$147.70 M(-60.0%)
Jun 2023
-
$368.97 M(+20.4%)
Mar 2023
-
$306.34 M(-42.4%)
Dec 2022
$2.24 B(+19.1%)
$531.71 M(-29.6%)
Sep 2022
-
$755.49 M(+12.9%)
Jun 2022
-
$668.88 M(+69.2%)
Mar 2022
-
$395.38 M(+301.6%)
Dec 2021
$1.88 B(+329.1%)
$98.46 M(-79.7%)
Sep 2021
-
$485.99 M(-24.5%)
Jun 2021
-
$643.85 M(-1.8%)
Mar 2021
-
$655.86 M(+6950.8%)
Dec 2020
$439.11 M(+196.2%)
$9.30 M(-97.3%)
Sep 2020
-
$350.97 M(+567.7%)
Jun 2020
-
$52.56 M(+100.1%)
Mar 2020
-
$26.27 M(-30.0%)
Dec 2019
$148.26 M(-28.8%)
$37.52 M(+41.5%)
Sep 2019
-
$26.51 M(-33.8%)
Jun 2019
-
$40.02 M(-9.5%)
Mar 2019
-
$44.20 M(-16.0%)
Dec 2018
$208.21 M(+2.6%)
$52.64 M(+6.1%)
Sep 2018
-
$49.63 M(-5.9%)
Jun 2018
-
$52.77 M(-0.8%)
Mar 2018
-
$53.17 M(-8.6%)
Dec 2017
$202.89 M(-28.7%)
$58.20 M(+16.4%)
Sep 2017
-
$49.98 M(+3.7%)
Jun 2017
-
$48.20 M(+3.6%)
Mar 2017
-
$46.51 M(-21.8%)
Dec 2016
$284.47 M(+47.0%)
$59.44 M(-10.7%)
Sep 2016
-
$66.54 M(-15.8%)
Jun 2016
-
$79.00 M(-0.6%)
Mar 2016
-
$79.48 M(-6.2%)
Dec 2015
$193.49 M(+69.2%)
$84.75 M(+113.4%)
Sep 2015
-
$39.72 M(+14.1%)
Jun 2015
-
$34.82 M(+1.8%)
Mar 2015
-
$34.19 M(-10.9%)
Dec 2014
$114.35 M(+55.9%)
$38.39 M(+37.1%)
Sep 2014
-
$28.00 M(+7.3%)
Jun 2014
-
$26.11 M(+19.5%)
Mar 2014
-
$21.85 M(-5.0%)
Dec 2013
$73.35 M(+41.8%)
$23.00 M(+14.5%)
Sep 2013
-
$20.08 M(+22.2%)
Jun 2013
-
$16.43 M(+18.7%)
Mar 2013
-
$13.84 M(-1.6%)
Dec 2012
$51.74 M(+42.7%)
$14.06 M(+11.5%)
Sep 2012
-
$12.61 M(-2.7%)
Jun 2012
-
$12.96 M(+7.0%)
Mar 2012
-
$12.11 M(+19.8%)
Dec 2011
$36.27 M(-6.6%)
$10.10 M(+12.6%)
Sep 2011
-
$8.98 M(+0.6%)
Jun 2011
-
$8.92 M(+8.0%)
Mar 2011
-
$8.26 M(+16.7%)
Dec 2010
$38.84 M
$7.08 M(-33.9%)
Sep 2010
-
$10.71 M(+13.1%)
DateAnnualQuarterly
Jun 2010
-
$9.47 M(-18.1%)
Mar 2010
-
$11.56 M(-18.7%)
Dec 2009
$37.71 M(+6.4%)
$14.23 M(+68.1%)
Sep 2009
-
$8.46 M(+7.7%)
Jun 2009
-
$7.86 M(+9.8%)
Mar 2009
-
$7.16 M(-22.9%)
Dec 2008
$35.42 M(+11.5%)
$9.28 M(-6.5%)
Sep 2008
-
$9.92 M(+16.1%)
Jun 2008
-
$8.55 M(+11.3%)
Mar 2008
-
$7.68 M(+187.9%)
Dec 2007
$31.78 M(+39.1%)
$2.67 M(-74.8%)
Sep 2007
-
$10.57 M(+19.0%)
Jun 2007
-
$8.88 M(+7.0%)
Mar 2007
-
$8.30 M(+373.7%)
Dec 2006
$22.85 M(+136.6%)
$1.75 M(-74.6%)
Sep 2006
-
$6.89 M(-12.6%)
Jun 2006
-
$7.88 M(+24.3%)
Mar 2006
-
$6.34 M(-155.8%)
Dec 2005
$9.66 M(-70.5%)
-$11.36 M(-376.9%)
Sep 2005
-
$4.10 M(-45.6%)
Jun 2005
-
$7.54 M(-19.6%)
Mar 2005
-
$9.38 M(-21.5%)
Dec 2004
$32.72 M(+17.5%)
$11.95 M(+302.1%)
Sep 2004
-
$2.97 M(-71.3%)
Jun 2004
-
$10.35 M(+27.5%)
Mar 2004
-
$8.12 M(+14.2%)
Dec 2003
$27.84 M(-23.9%)
$7.11 M(-1.7%)
Sep 2003
-
$7.23 M(+4.7%)
Jun 2003
-
$6.91 M(+4.7%)
Mar 2003
-
$6.59 M(+0.1%)
Dec 2002
$36.56 M(+9.7%)
$6.59 M(-25.2%)
Sep 2002
-
$8.81 M(-11.8%)
Jun 2002
-
$9.98 M(-10.8%)
Mar 2002
-
$11.19 M(+22.1%)
Dec 2001
$33.32 M(+119.0%)
$9.16 M(+23.7%)
Sep 2001
-
$7.41 M(-23.0%)
Jun 2001
-
$9.63 M(+35.2%)
Mar 2001
-
$7.12 M(+20.8%)
Dec 2000
$15.22 M(+162.4%)
$5.89 M(+57.3%)
Sep 2000
-
$3.75 M(+9.7%)
Jun 2000
-
$3.42 M(+57.7%)
Mar 2000
-
$2.17 M(+20.3%)
Dec 1999
$5.80 M(-1.7%)
$1.80 M(-5.3%)
Sep 1999
-
$1.90 M(+72.7%)
Jun 1999
-
$1.10 M(+10.0%)
Mar 1999
-
$1.00 M(-47.4%)
Dec 1998
$5.90 M(+11.3%)
$1.90 M(+26.7%)
Sep 1998
-
$1.50 M(+7.1%)
Jun 1998
-
$1.40 M(+27.3%)
Mar 1998
-
$1.10 M(-21.4%)
Dec 1997
$5.30 M(-5.4%)
$1.40 M(+7.7%)
Sep 1997
-
$1.30 M(-7.1%)
Jun 1997
-
$1.40 M(+16.7%)
Mar 1997
-
$1.20 M(-33.3%)
Dec 1996
$5.60 M
$1.80 M(+63.6%)
Sep 1996
-
$1.10 M(-21.4%)
Jun 1996
-
$1.40 M(+16.7%)
Mar 1996
-
$1.20 M

FAQ

  • What is Novavax annual total expenses?
  • What is the all time high annual total expenses for Novavax?
  • What is Novavax annual total expenses year-on-year change?
  • What is Novavax quarterly total expenses?
  • What is the all time high quarterly total expenses for Novavax?
  • What is Novavax quarterly total expenses year-on-year change?

What is Novavax annual total expenses?

The current annual total expenses of NVAX is $1.12 B

What is the all time high annual total expenses for Novavax?

Novavax all-time high annual total expenses is $2.24 B

What is Novavax annual total expenses year-on-year change?

Over the past year, NVAX annual total expenses has changed by -$1.12 B (-49.95%)

What is Novavax quarterly total expenses?

The current quarterly total expenses of NVAX is $218.53 M

What is the all time high quarterly total expenses for Novavax?

Novavax all-time high quarterly total expenses is $755.49 M

What is Novavax quarterly total expenses year-on-year change?

Over the past year, NVAX quarterly total expenses has changed by +$70.83 M (+47.96%)